Assiut University

🇪🇬Egypt

Country: 🇪🇬Egypt

Ownership: Private

Established: 1957-10-01

Employees: 5K

Market Cap: -

Website: http://www.aun.edu.eg

Clinical Trials

Adaptation and Validation of the Arabic Version of EuroQol 5D-5L

Conditions: Validation Study

First Posted Date: 2018-04-20

Last Posted Date: 2018-04-20

Lead Sponsor: Assiut University

Target Recruit Count: 160

Registration Number: NCT03504384

Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion

Phase 1

Completed

Conditions: Cancer, Breast

Interventions: Drug: Normal saline
Drug: Lidocaine

First Posted Date: 2018-04-18

Last Posted Date: 2018-04-19

Lead Sponsor: Assiut University

Target Recruit Count: 80

Registration Number: NCT03502395

Locations: 🇪🇬
Assiut university faculty of medicine, Assiut, Egypt

VATS Evacuation Compared to Reinsertion of Thoracostomy Tube in Persistent Traumatic Haemothorax

Not Applicable

Completed

Conditions: Hemothorax; Traumatic

Interventions: Device: VATS evacuation
Device: thoracostomy tube

First Posted Date: 2018-04-18

Last Posted Date: 2025-01-20

Lead Sponsor: Assiut University

Target Recruit Count: 2

Registration Number: NCT03501524

Locations: 🇪🇬
Assiut university, Assiut, Egypt

Prediction of Leg Length Discrepancy After Unilateral Total Knee Replacement in Varus Deformity

Not Applicable

Conditions: Total Knee Replacement

Interventions: Diagnostic Test: x-ray

First Posted Date: 2018-04-18

Last Posted Date: 2018-04-19

Lead Sponsor: Assiut University

Target Recruit Count: 50

Registration Number: NCT03502382

Locations: 🇪🇬
Assiut University, Assiut, Egypt

Effect of Early Feeding of Breast Milk

Not Applicable

Conditions: Weight Gain
Feeding Disorder Neonatal
Neonatal SEPSIS

Interventions: Other: preterm formula milk
Other: exclusive breast milk

First Posted Date: 2018-04-17

Last Posted Date: 2018-04-17

Lead Sponsor: Assiut University

Target Recruit Count: 100

Registration Number: NCT03498989

Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease

Phase 4

Completed

Conditions: HCV Coinfection
End-stage Renal Disease

Interventions: Drug: Ombitasvir / Paritaprevir / Ritonavir /Ribavirin Oral Tablet

First Posted Date: 2018-04-17

Last Posted Date: 2020-01-10

Lead Sponsor: Assiut University

Target Recruit Count: 110

Registration Number: NCT03499639

Locations: 🇪🇬
Assiut University Hopsital, Assiut, Egypt

Ureteral Stent Versus Percutaneous Nephrostomy in Acutely Obstructed Infected Kidney

Not Applicable

Completed

Conditions: Management of Obstructed Infected Kidney

Interventions: Procedure: Ureteral stent

First Posted Date: 2018-04-17

Last Posted Date: 2020-05-11

Lead Sponsor: Assiut University

Target Recruit Count: 2

Registration Number: NCT03498794

Locations: 🇪🇬
Mahmoud magdy, Assiut, Egypt

Vitamin D Status in Inflammatory Bowel Disease

Not Applicable

Conditions: Inflammatory Bowel Diseases
Vitamin D Deficiency

Interventions: Diagnostic Test: serum total 25 hydroxycholecalciferol 25(OH) vitamin D
Diagnostic Test: complete blood count (CBC)
Diagnostic Test: serum calcium level
Diagnostic Test: erythrocyte sedimentation rate (ESR)
Diagnostic Test: C-reactive protein (CRP)
Diagnostic Test: serum creatinine
Diagnostic Test: serum albumin level
Diagnostic Test: seum alanine aminotransferase
Diagnostic Test: serum potassium level
Diagnostic Test: serum phosphurus level